|
1
|
Bergstrand CG and Csar B: Demonstration of
a new protein fraction in serum from the human fetus. Scand J Clin
Lab Invest. 8:1741956. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith JB: Alpha-fetoprotein: Occurrence in
certain malignant diseases and review of clinical applications. Med
Clin North Am. 54:797–803. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kodama T, Kameya T, Hirota T, Shimosato Y,
Ohkura H, Mukojima T and Kitaoka H: Production of
alpha-fetoprotein, normal serum proteins, and human chorionic
gonadotropin in stomach cancer: Histologic and immunohistochemical
analyses of 35 cases. Cancer. 48:1647–1655. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ishikura H, Kirimoto K, Shamoto M,
Miyamoto Y, Yamagiwa H, Itoh T and Aizawa M: Hepatoid
adenocarcinomas of the stomach. An analysis of seven cases. Cancer.
58:119–126. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang YC, Nagasue N, Kohno H, Taniura H,
Uchida M, Yamanoi A, Kimoto T and Nakamura T: Clinicopathologic
features and long-term results of alpha-fetoprotein-producing
gastric cancer. Am J Gastroenterol. 85:1480–1485. 1990.PubMed/NCBI
|
|
6
|
Adachi Y, Tsuchihashi J, Shiraishi N,
Yasuda K, Etoh T and Kitano S: AFP-producing gastric carcinoma:
Multivariate analysis of prognostic factors in 270 patients.
Oncology. 65:95–101. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inoue M, Sano T, Kuchiba A, Taniguchi H,
Fukagawa T and Katai H: Long-term results of gastrectomy for
alpha-fetoprotein-producing gastric cancer. Br J Surgery.
97:1056–1061. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirajima S, Komatsu S, Ichikawa D, Kubota
T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Ikoma H and Otsuji
E: Liver metastasis is the only independent prognostic factor in
AFP-producing gastric cancer. World J Gastroenterol. 19:6055–6061.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsurumachi T, Yamamoto H, Watanabe K,
Honda I, Watanabe S, Yamada S, Jingu K, Satomi D and Fujita M:
Resection of liver metastasis from alpha-fetoprotein-producing
early gastric cancer: Report of a case. Surg Today. 27:563–566.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Asahi Y, Kamiyama T, Homma S, Hatanaka KC,
Yokoo H, Nakagawa T, Kamachi H, Nakanishi K, Tahara M, Kakisaka T,
et al: Resection of liver metastasis derived from
alpha-fetoprotein-producing gastric cancer-report of 4 cases. Int
Canc Conf J. 5:98–103. 2016. View Article : Google Scholar
|
|
11
|
Benson AB, D'Angelica MI, Abbott DE, Anaya
DA, Anders R, Are C, Bachini M, Borad M, Brown D, Burgoyne A, et
al: Hepatobiliary cancers, version 2.2021, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 19:541–565. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kimura T, Fujiwara T, Kameoka T, Adachi Y
and Kariya S: The current role of stereotactic body radiation
therapy (SBRT) in hepatocellular carcinoma (HCC). Cancers (Basel).
14:43832022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Japanese Gastric Cancer Association, .
Japanese Classification of Gastric Carcinoma-2nd English Edition.
Gastric Cancer. 1:10–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fernandez LM, São Julião GP, Figueiredo
NL, Beets GL, van der Valk MJM, Bahadoer RR, Hilling DE,
Meershoek-Klein Kranenbarg E, Roodvoets AGH, Renehan AG, et al:
Conditional recurrence-free survival of clinical complete
responders managed by watch and wait after neoadjuvant
chemoradiotherapy for rectal cancer in the International Watch
& Wait Database: A retrospective, international, multicentre
registry study. Lancet Oncol. 22:43–45. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyazaki T, Sohda M, Sakai M, Kumakura Y,
Yoshida T, Kuriyama K, Yokobori T, Miyazaki M, Hirato J, Okumura T,
et al: Multimodality therapy including proton beam therapy for AFP
producing esophageal cancer with multiple liver metastases. Intern
Med. 57:2333–2339. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kodera Y, Fujitani K, Fukushima N, Ito S,
Muro K, Ohashi N, Yoshikawa T, Kobayashi D, Tanaka C and Fujiwara
M: Surgical resection of hepatic metastasis from gastric cancer: A
review and new recommendation in the Japanese gastric cancer
treatment guidelines. Gastric Cancer. 17:206–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shirasu H, Tsushima T, Kawahira M, Kawai
S, Kawakami T, Kito Y, Yoshida Y, Hamauchi S, Todaka A, Yokota T,
et al: Role of hepatectomy in gastric cancer with multiple
liver-limited metastases. Gastric Cancer. 21:338–344. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rusthoven KE, Kavanagh BD, Cardenes H,
Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin
W, Kane M, et al: Multi-institutional phase I/II trial of
stereotactic body radiation therapy for liver metastases. J Clin
Oncol. 27:1572–1578. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Palma DA, Olson R, Harrow S, Gaede S,
Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP,
et al: Stereotactic ablative radiotherapy versus standard of care
palliative treatment in patients with oligometastatic cancers
(SABR-COMET): a randomised, phase 2, open-label trial. Lancet.
393:2051–2058. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ushiku T, Shinozaki A, Shibahara J,
Iwasaki Y, Tateishi Y, Funata N and Fukayama M: SALL4 represents
fetal gut differentiation of gastric cancer, and is diagnostically
useful in distinguishing hepatoid gastric carcinoma from
hepatocellular carcinoma. Am J Surg Pathol. 34:533–540. 2010.
View Article : Google Scholar : PubMed/NCBI
|
